[Managing side effects of androgene deprivation in prostate cancer].
作者信息
Thalgott Mark, Gschwend Jürgen E, Retz Margitta
机构信息
Urologische Klinik und Poliklinik der TU München, Klinikum rechts der Isar.
出版信息
MMW Fortschr Med. 2010 Oct 14;152(41):40-3.
PMID:21090376
Abstract
摘要
相似文献
1
[Managing side effects of androgene deprivation in prostate cancer].[前列腺癌雄激素剥夺治疗的副作用管理]
MMW Fortschr Med. 2010 Oct 14;152(41):40-3.
2
Should we follow-up serum testosterone in patients with advanced prostate cancer?我们是否应该对晚期前列腺癌患者进行血清睾酮随访？
Expert Rev Anticancer Ther. 2010 Jul;10(7):1031-5. doi: 10.1586/era.10.92.
3
Castration refractory prostate cancer: cinderella finally comes to the ball.去势抵抗性前列腺癌：灰姑娘终于步入舞会。
Onkologie. 2010;33(12):655-6. doi: 10.1159/000322635. Epub 2010 Nov 29.
4
Hormonal treatment of prostate cancer.前列腺癌的激素治疗
N Engl J Med. 1999 Mar 11;340(10):812-3. doi: 10.1056/NEJM199903113401015.
5
Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.治疗激素难治性前列腺癌的无症状患者：泌尿外科医生的激素治疗方法
BJU Int. 2008 Mar;101(6):671-4. doi: 10.1111/j.1464-410X.2007.07336.x. Epub 2007 Dec 7.
6
[Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].[完全激素阻断与单纯激素阻断治疗前列腺癌的比较]
Arch Esp Urol. 2002 Sep;55(7):771-5.
7
Androgen deprivation therapy for prostate cancer.前列腺癌的雄激素剥夺疗法。
J Urol. 2007 Oct;178(4 Pt 1):1148. doi: 10.1016/j.juro.2007.07.066. Epub 2007 Aug 14.
8
Endocrine treatment of prostate cancer.前列腺癌的内分泌治疗
J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. doi: 10.1016/j.jsbmb.2004.10.005. Epub 2004 Dec 31.
9
Editorial: hormone therapies for prostate cancer--acute disease control, chronic disease progression.
J Urol. 2003 Apr;169(4):1558. doi: 10.1097/01.ju.0000056992.26783.33.
10
How should we understand the term androgen deprivation therapy?我们应该如何理解雄激素剥夺疗法这个术语？
Eur Urol. 2012 Apr;61(4):856. doi: 10.1016/j.eururo.2012.01.016. Epub 2012 Jan 17.
Zotero 插件